Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Boehringer Ingelheim identifies new pantetheinase inhibitors

June 29, 2020

Positive phase I/IIa results presented for AIV-001 in dermal scarring

June 29, 2020

Patient genetic variants linked to wound microbiomes

June 26, 2020

Reistone begins dosing in phase II study of SHR-0302 for alopecia areata

June 19, 2020

TOPADUR Pharma presents dual PDE5A inhibitors/soluble guanylate cyclase activators

June 17, 2020

Vyome releases positive phase II results for VB-1953

June 17, 2020

Positive data reported from phase II AFFIRM-35 study of ABY-035

June 17, 2020

Nflection Therapeutics divulges new MAP2K1 inhibitors

June 12, 2020

NFlection initiates phase IIa study of NFX-179 gel for cutaneous NF-1

June 10, 2020

Pfizer reports topline data from JADE TEEN trial of abrocitinib in adolescent atopic dermatitis

June 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...